Growth Metrics

Usana Health Sciences (USNA) Net Cash Flow (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Net Cash Flow for 16 consecutive years, with $11.2 million as the latest value for Q1 2026.

  • Quarterly Net Cash Flow rose 106.33% to $11.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$28.4 million through Jan 2026, up 80.09% year-over-year, with the annual reading at -$28.4 million for FY2026, 80.09% up from the prior year.
  • Net Cash Flow for Q1 2026 was $11.2 million at Usana Health Sciences, up from -$6.1 million in the prior quarter.
  • The five-year high for Net Cash Flow was $37.0 million in Q4 2022, with the low at -$176.4 million in Q4 2024.
  • Average Net Cash Flow over 5 years is -$10.6 million, with a median of $5.1 million recorded in 2024.
  • The sharpest move saw Net Cash Flow skyrocketed 1542.61% in 2023, then crashed 1011.32% in 2024.
  • Over 5 years, Net Cash Flow stood at $37.0 million in 2022, then plummeted by 47.72% to $19.4 million in 2023, then plummeted by 1011.32% to -$176.4 million in 2024, then soared by 96.52% to -$6.1 million in 2025, then soared by 282.03% to $11.2 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $11.2 million, -$6.1 million, and -$30.6 million for Q1 2026, Q3 2025, and Q2 2025 respectively.